Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Kalbe Farma Tbk (KLBF) Price & Performance

Cipta Sarana Medika Tbk.Trade
Kalbe Farma TbkTrade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Kalbe Farma Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 233.1× Cipta Sarana Medika Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 14.05M). Which is the better fit depends on your goals.

DKHHKLBF
Market Cap
160.67B37.45T
Volume
14.05M41.79M
Lot
140.49K417.89K
Turnover
899.67M33.46B
Average Price
64.04800.79
Value
899.67M33.46B
Indicative Equilibrium Price
64800
Indicative Equilibrium Volume
10018.3K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
KLBF
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Kalbe Farma Tbk

PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.

Read more on KLBF